Review article:: test and treat or test and scope for Helicobacter pylori infection.: Any change in gastric cancer prevention?

被引：7

作者：

Mc Loughlin, RM

Sebastian, SS

O'Connor, HJ

Buckley, M

O'Morain, CA ^{[1
]}

机构：

[1] Adelaide & Meath Hosp, Dublin 24, Ireland

[2] Univ Dublin Trinity Coll, Dublin 2, Ireland

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2003年 / 17卷

关键词：

D O I：

10.1046/j.1365-2036.17.s2.13.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

A 'test and treat' strategy is advocated for patients with dyspepsia under the age of 45 years, with endoscopy reserved for those with alarm symptoms or aged over 45 years. One of the consequences of this strategy will be a reduction in population infection rates of Helicobacter pylori. It is now clear that H. pylori is one of the prime initiators of gastric cancer with up to 70% of gastric cancers attributable to H. pylori. What remains unclear is if H. pylori reduction will lead to a reduction in gastric cancer.

引用

页码：82 / 88

页数：7

共 73 条

[1]

Annibale B, 2000, ALIMENT PHARM THERAP, V14, P625

[2]

[Anonymous], 1994, INFECT HELICOBACTER, V61, P177

[3]

Azuma T, 1998, CANCER, V82, P1013, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1013::AID-CNCR2>3.0.CO

[4]

2-F